These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5167038)

  • 1. Effects of compound 48-80 on immune haemolysis: enhancement of C1 site formation and inhibition of C4 site formation.
    Yamamoto S; Okada H; Yamura T; Sindo T
    Immunology; 1971 Dec; 21(6):939-41. PubMed ID: 5167038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Cu-chlorophyllin on the active site formation of each component of guinea-pig complement.
    Okada H; Nishioka K; Sindo T
    Immunology; 1969 Apr; 16(4):473-80. PubMed ID: 5770389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the effects of compound 48-80 on complement activity].
    Yamamoto S
    Arerugi; 1969 Jan; 18(1):70-80. PubMed ID: 4181010
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. I. Functional differences among C4 sites on cell surfaces.
    Borsos T; Rapp HJ; Colten HR
    J Immunol; 1970 Dec; 105(6):1439-46. PubMed ID: 4991793
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of immune haemolysis by bovine serum albumin.
    Friedman HP; Williams MO; Muraski F
    Cytobios; 1971 Dec; 4(15):245-53. PubMed ID: 5151651
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition by zinc of the binding of C1 to antigen-antibody complexes.
    Boyle MD
    Biochem Biophys Res Commun; 1981 Dec; 103(3):856-62. PubMed ID: 7332580
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of inhibition of the action of C1 on C4 by two synthetic substrates of C1 esterase, TAMe and ATEe.
    Shimada A; Tamura N
    Immunology; 1972 May; 22(5):723-31. PubMed ID: 5063184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
    Takahashi M; Takahashi S; Hirose S
    Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitamin A: probe of immune complement reactions. 3. Inhibition of guinea pig complement hemolysis.
    Westfall SS; Wirtz GH
    Immunochemistry; 1972 May; 9(5):505-12. PubMed ID: 5036148
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the eighth component of complement (C8) by ethylenediaminetetra-acetate (EDTA).
    Schultz DR; Zarco RM
    J Immunol; 1970 Feb; 104(2):279-88. PubMed ID: 4983887
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of bovine complement. I. Formation of a lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):28-33. PubMed ID: 5091959
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of phagocytosis by Compound 48/80 and its influence upon Ca++-dependent ATP-ase.
    Falke D; Lemmel EM; Richardson LS; Wolf HU
    Arzneimittelforschung; 1975 Aug; 25(8):1258-61. PubMed ID: 170946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune haemolysis: reaction of the terminal complement component.
    Götze O; Haupt I; Fischer H
    Nature; 1968 Mar; 217(5134):1165-7. PubMed ID: 4966850
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. IV. Formation of EAC42 by treatment of C2 with trypsin in the presence of EAC4.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Sep; 109(3):434-8. PubMed ID: 5055179
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
    Bing DH
    J Immunol; 1970 Nov; 105(5):1289-91. PubMed ID: 5489072
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental study of the sensitizing properties of the antibiotics phytobacteriomycin and polymycin].
    Mel'nikova EA
    Antibiotiki; 1971 Oct; 16(10):911-6. PubMed ID: 4333190
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation and partial characterization of sheep erythrocyte-antibody-complement intermediate.
    Rommel FA; Stolfi R
    Immunology; 1968 Oct; 15(4):469-79. PubMed ID: 5696260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.